ORIG3N   Report issue

For profit
Founded: Boston MA United States (2014)
Status: No NME R&D (2014)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Other Trials (4)

Key: ORIG3N (0) Acquired (4)

aframomum melegueta extract (1 trial)

blueberry/blackberry extract (1 trial)

reseveravine (1 trial)

rose hips extract (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 1
  • # of Trial APIs: 4